AVROBIO INC (AVRO) Stock Analyst Ratings
NASDAQ:AVRO - Nasdaq - US05455M1009 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to AVRO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.04. This target is 45.71% above the current price.
AVRO was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about AVRO.
In the previous month the buy percentage consensus was at a similar level.
AVRO was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-18 | Mizuho | Downgrade | Buy -> Neutral |
| 2023-07-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-07-12 | Wedbush | Downgrade | Outperform -> Neutral |
| 2023-03-24 | Mizuho | Maintains | Buy |
| 2023-03-24 | Needham | Reiterate | Buy |
| 2022-12-08 | BTIG | Upgrade | Neutral -> Buy |
| 2022-05-17 | Needham | Maintains | Buy |
| 2022-05-11 | Barclays | Maintains | Overweight |
| 2022-01-06 | Mizuho | Maintains | Buy |
| 2022-01-05 | BTIG | Downgrade | Buy -> Neutral |
| 2022-01-05 | Needham | Maintains | Buy |
| 2022-01-05 | Barclays | Maintains | Overweight |
| 2022-01-05 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-11-19 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2021-10-12 | Morgan Stanley | Maintains | Overweight |
| 2021-07-16 | Morgan Stanley | Maintains | Overweight |
| 2021-06-15 | BTIG | Initiate | Buy |
| 2021-05-27 | Needham | Maintains | Buy |
| 2021-05-14 | Morgan Stanley | Maintains | Overweight |
| 2021-05-03 | SVB Leerink | Maintains | Market Perform |
| 2021-03-09 | Barclays | Initiate | Overweight |
| 2021-03-02 | Stifel | Initiate | Hold |